Sewoon Medical Income Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	64,489	63,657	60,151	68,247	60,116	62,579
Other Revenue	-	-	-	-0	-	-
Revenue	64,489	63,657	60,151	68,247	60,116	62,579
Revenue Growth (YoY)	7.71%	5.83%	-11.86%	13.53%	-3.94%	-1.80%
Cost of Revenue	40,162	40,112	37,963	40,689	37,896	37,522
Gross Profit	24,326	23,545	22,188	27,557	22,220	25,057
Selling, General & Admin	9,609	9,454	9,468	9,330	8,734	8,466
Research & Development	463.48	456.39	510.42	468.21	505.09	427.87
Amortization of Goodwill & Intangibles	229.52	242.33	149.71	143.91	152.41	87.82
Operating Expenses	10,999	10,844	10,811	10,637	10,033	9,671
Operating Income	13,327	12,701	11,377	16,920	12,187	15,386
Interest Expense	-32.51	-35.52	-36.63	-36.08	-35.81	-31.47
Interest & Investment Income	2,079	2,065	2,331	1,969	736.18	172.83
Currency Exchange Gain (Loss)	633.54	143.09	1,597	357.41	702.87	1,035
Other Non Operating Income (Expenses)	0.72	-7.96	73.35	69.67	38.25	67.05
EBT Excluding Unusual Items	16,008	14,865	15,342	19,280	13,629	16,630
Gain (Loss) on Sale of Assets	22.71	36.61	279.54	17.79	2.2	-0.67
Asset Writedown	-	-	-	-	-2	-2.96
Pretax Income	16,031	14,902	15,621	19,298	13,629	16,626
Income Tax Expense	3,045	2,709	3,046	3,824	2,990	3,864
Earnings From Continuing Operations	12,986	12,193	12,575	15,474	10,639	12,762
Net Income to Company	12,986	12,193	12,575	15,474	10,639	12,762
Minority Interest in Earnings	-371.79	-280.57	-412.61	-517.02	-232.69	-480.5
Net Income	12,614	11,912	12,163	14,957	10,406	12,282
Net Income to Common	12,614	11,912	12,163	14,957	10,406	12,282
Net Income Growth	13.26%	-2.06%	-18.68%	43.73%	-15.27%	17.02%
Shares Outstanding (Basic)	43	43	43	43	43	43
Shares Outstanding (Diluted)	43	43	43	43	43	43
Shares Change (YoY)	-1.77%	-1.18%	-0.02%	-	-	-
EPS (Basic)	296.59	278.50	281.00	345.50	240.38	283.70
EPS (Diluted)	296.59	278.50	281.00	345.50	240.38	283.70
EPS Growth	15.41%	-0.89%	-18.67%	43.73%	-15.27%	17.02%
Free Cash Flow	15,667	16,083	11,750	21,127	7,128	19,244
Free Cash Flow Per Share	368.37	376.01	271.47	488.02	164.65	444.53
Dividend Per Share	-	-	-	70.000	60.000	50.000
Dividend Growth	-	-	-	16.67%	20.00%	-
Gross Margin	37.72%	36.99%	36.89%	40.38%	36.96%	40.04%
Operating Margin	20.67%	19.95%	18.91%	24.79%	20.27%	24.59%
Profit Margin	19.56%	18.71%	20.22%	21.92%	17.31%	19.63%
Free Cash Flow Margin	24.29%	25.26%	19.54%	30.96%	11.86%	30.75%
EBITDA	16,586	16,021	14,857	20,568	16,075	19,222
EBITDA Margin	25.72%	25.17%	24.70%	30.14%	26.74%	30.72%
D&A For EBITDA	3,259	3,320	3,480	3,648	3,888	3,836
EBIT	13,327	12,701	11,377	16,920	12,187	15,386
EBIT Margin	20.67%	19.95%	18.91%	24.79%	20.27%	24.59%
Effective Tax Rate	19.00%	18.18%	19.50%	19.82%	21.94%	23.24%
Advertising Expenses	-	281.21	294.06	233.54	186.34	76.21